Tombak, A. Et Al. 2021. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.. Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.38, no.4 , 273-285.

Tombak, A., Pepedil Tanrıkulu, F., Durusoy, S. S., Dinçyürek, H. D., Kaya, E., Ümit, E. G., ... Yavaşoğlu, İ.(2021). Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.. Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.38, no.4, 273-285.

Tombak, Anıl Et Al. "Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.," Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.38, no.4, 273-285, 2021

Tombak, Anıl Et Al. "Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.." Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.38, no.4, pp.273-285, 2021

Tombak, A. Et Al. (2021) . "Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.." Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.38, no.4, pp.273-285.

@article{article, author={Anıl Tombak Et Al. }, title={Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.}, journal={Turkish journal of haematology : official journal of Turkish Society of Haematology}, year=2021, pages={273-285} }